These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28429331)

  • 1. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
    Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P
    Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD19
    Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
    Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
    Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
    Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1
    Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
    Front Immunol; 2018; 9():2241. PubMed ID: 30327652
    [No Abstract]   [Full Text] [Related]  

  • 5. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.
    Flores-Borja F; Bosma A; Ng D; Reddy V; Ehrenstein MR; Isenberg DA; Mauri C
    Sci Transl Med; 2013 Feb; 5(173):173ra23. PubMed ID: 23427243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased number of CD19
    Li T; Yu Z; Qu Z; Zhang N; Crew R; Jiang Y
    Mol Immunol; 2019 Aug; 112():233-239. PubMed ID: 31181422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.
    Blair PA; Noreña LY; Flores-Borja F; Rawlings DJ; Isenberg DA; Ehrenstein MR; Mauri C
    Immunity; 2010 Jan; 32(1):129-40. PubMed ID: 20079667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficit of circulating CD19
    Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
    Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD24
    Xu C; Zhang M; Li K; Ni M; Bai Y; Zhang J; Song X; Wang J
    Int Immunopharmacol; 2019 May; 70():295-301. PubMed ID: 30851710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of CD19
    Zhao Q; Jung LK
    Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in the proportion of CD24
    Wang Y; Qin Y; Wang X; Zhang L; Wang J; Xu X; Chen H; Hsu HT; Zhang M
    Clin Exp Immunol; 2020 Apr; 200(1):22-32. PubMed ID: 31849037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of CD19⁺CD24(hi)CD38(hi) regulatory B cells is associated with a reduced risk of acute lung injury in elderly pneumonia patients.
    Song H; Xi J; Li GG; Xu S; Wang C; Cheng T; Li H; Zhang Y; Liu X; Bai J
    Intern Emerg Med; 2016 Apr; 11(3):415-23. PubMed ID: 26758063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated circulating CD19
    Deng B; Deng L; Liu M; Zhao Z; Huang H; Tu X; Liang E; Tian R; Wang X; Wang R; Lin H; Yu Y; Peng A; Xu P; Bao K; He M
    Immunol Lett; 2023 Sep; 261():58-65. PubMed ID: 37553031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
    Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
    Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective CD19+CD24
    Cencioni MT; Ali R; Nicholas R; Muraro PA
    Mult Scler; 2021 Jul; 27(8):1187-1197. PubMed ID: 32924828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and Immunophenotypic Characterization of Human CD19
    Bradford HF; Mauri C
    Methods Mol Biol; 2021; 2270():77-90. PubMed ID: 33479894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major.
    Zahran AM; Elsayh KI; Saad K; Embaby M; Ali AM
    Blood Cells Mol Dis; 2016 Mar; 57():91-6. PubMed ID: 26852663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD19
    Gu Y; Li K; Sun J; Zhang J
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2863-2870. PubMed ID: 32242984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
    Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
    Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.